Edgar Amorín

Learn More
INTRODUCTION Frequency of mutations in EGFR and KRAS in non-small cell lung cancer (NSCLC) is different between ethnic groups; however, there is no information in Latin-American population. METHODS A total of 1150 biopsies of NSCLC patients from Latin America (Argentina, Colombia, Peru, and Mexico) were used extracting genomic DNA to perform direct(More)
Against a backdrop of global equity in cancer prevention and control, the National Institute of Neoplastic Diseases (INEN), a national reference center, has designed and developed innovative strategies and programs with the intent to meet institutional goals through health promotion interventions and cancer prevention, diagnosis, and treatments that benefit(More)
Following the implementation of the National Cancer Prevention and Control Results-based Budget Programme (PpR Cancer-024) in 2011, the Peruvian Government approved the Plan Esperanza-a population-based national cancer control plan-in 2012. Legislation that ensured full government-supported funding for people who were otherwise unable to access or afford(More)
e21155 Background: Epidermal Growth Factor Receptor (EGFR) and K-ras are key pathways in NSCLC; mutations in these genes determine a subgroup of patients with different prognosis and therapeutic approach. The frequency of mutations varies between different ethnic groups; so far, EGFR and K-ras mutations have not been described in the LATAM population. (More)
  • 1